Psychedelics Recent News

Russell Newcombe Dies - Legacy Of UK's Longtime Harm Reduction Advocate, Committed Drug Researcher
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
At 77, Cannabis Champion Dana Beal Fights Idaho Laws To Push Legalization In Hostile Territory
Two Top Biotechs Forge MDMA Supply Deals For An Expanding Research Field